Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: pattern of progression in responders and patients with stable disease with or without resection of residual lesions.
Eur J Cancer
; 30A(7): 955-8, 1994.
Article
en En
| MEDLINE
| ID: mdl-7946591
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Interleucina-2
/
Interferón-alfa
/
Inmunoterapia
/
Melanoma
Tipo de estudio:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Año:
1994
Tipo del documento:
Article